TAM CHANG: Open Payments
NPI 1861537458 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 19 payments from 5 companies in 2025. Trend: 2023 $404 · 2024 $185 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $163 |
| Gilead Sciences, Inc. | 5 | $105 |
| Lilly USA, LLC | 1 | $29 |
| PFIZER INC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: GEMTESA, MOUNJARO, PAXLOVID.
Industry payments across MA — which companies pay providers there.
